HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of acute urinary tract infection with low doses of sulfadiazine.

Abstract
The pharmacokinetics of sulfadiazine (SD) were studied and acute urinary tract infections treated with lower than usual doses of SD (500 mg twice daily and 250 mg twice daily). The therapeutic results were further compared to those obtained with a conventional dose of sulfamethoxazole (SM, 1000 mg twice daily). With both doses of SD adequate drug concentrations in serum and urine were obtained. The treatment results were equal to those with SM. The results of the trial were comparable to those generally achieved with sulfonamides in the treatment of acute urinary tract infections.
AuthorsJ Seppänen
JournalAnnals of clinical research (Ann Clin Res) Issue 25 Pg. 19-24 ( 1980) ISSN: 0003-4762 [Print] Finland
PMID7377745 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Sulfadiazine
  • Sulfamethoxazole
Topics
  • Acetylation
  • Acute Disease
  • Aged
  • Drug Resistance, Microbial
  • Humans
  • Kinetics
  • Sulfadiazine (administration & dosage, metabolism, therapeutic use)
  • Sulfamethoxazole (administration & dosage)
  • Urinary Tract Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: